Clinton H. Durney

Clinton H. Durney

Auto-generated profile, based on publicly available information

Clinton H. Durney

Department of Population Health Sciences BC Cancer Research Institute Vancouver Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2025 in New Phytologist
Verified
Journal Article
Open access
MWMatthew J. Wilson
Matthew J. Wilson
SMShauni McGregor
Shauni McGregor
CDClinton H. Durney
Clinton H. Durney
MTMelissa Tomkins
Melissa Tomkins
JAJodie Armand
Jodie Armand
AFAndrew J. Fleming
Andrew J. Fleming
Summary: Stomata regulate plant gas exchange via repeated turgor‐driven changes of guard cell shape, thereby adjusting pore apertures. Grasses, which are among the most widespread plant families on the planet, are distinguished by their unique stomatal structure, which is proposed to have significantly contributed to their evolutionary and agricultural success. One component of their structure, which has received little attention, is the presence of a discontinuous adjoining cell wall of the guard cell pair. Here, we demonstrate the presence of these symplastic connections in a range of grasses and use finite element method simulations to assess hypotheses for their functional significance. Our results show that opening of the stomatal pore is maximal when the turgor pressure in dumbbell‐shaped grass guard cells is equal, especially under the low pressure conditions that occur during the early phase of stomatal opening. By contrast, we demonstrate that turgor pressure differences have less effect on the opening of kidney‐shaped guard cells, characteristic of the majority of land plants, where guard cell connections are rarely or not observed. Our data describe a functional mechanism based on cellular mechanics, which plausibly facilitated a major transition in plant evolution and crop development.

30 December 2025 in Tobacco Control
Verified
Journal Article
Open access
CDClinton H Durney
Clinton H Durney
RMRafael Meza
Rafael Meza
EJEvelyn Jimenez-Mendoza
Evelyn Jimenez-Mendoza
KXKe Xu
Ke Xu
DLDavid Levy
David Levy
AFAbigail S Friedman
Abigail S Friedman
Background: The landscape of tobacco and nicotine delivery products has rapidly evolved with the introduction of electronic nicotine delivery systems (ENDSs) and oral nicotine pouches (ONPs). Understanding sales trends and flavour preferences is critical for assessing these products’ public health impact and informing regulatory strategies. Objective: To characterise recent trends in US sales of ENDS and ONPs from 2018 to 2023, overall and by flavour. Methods: Information Resources retail sales data covering 40 states from 7 January 2018 to 16 July 2023, were used to document trends in ENDS and ONP sales from brick-and-mortar retailers, by product flavour (non-menthol, mint/menthol and tobacco/unflavoured) in 4 week periods. Results: ENDS and ONP sales have shown significant growth, with notable fluctuations coinciding with public health concerns and regulatory announcements. Specifically, non-menthol flavoured ENDS initially experienced a decline in sales following regulatory actions in early 2020 but strongly rebounded thereafter. Meanwhile, ONP sales have increased steadily, dominated by mint/menthol flavours. These trends may reflect consumer flavour preferences as well as manufacturers’ strategic responses to policy changes. Sensitivity analyses using more recent sales data from 24 states confirm that these patterns persist. Conclusions: Differences in ENDS and ONP sales trends by flavour type underscore the importance of ongoing, detailed monitoring of nicotine product sales and use, to clarify public health implications and guide regulation. Given the growing variety of nicotine and tobacco products available today, tobacco regulatory frameworks must consider trends across this rapidly evolving market to understand and mitigate associated public health risks.

13 February 2026 in JTO Clinical and Research Reports
Verified
Journal Article
Open access
CDClinton H. Durney
Clinton H. Durney
ATAadetri Tawara
Aadetri Tawara
MBMichael Brauer
Michael Brauer
SASukhinder Atkar-Khattra
Sukhinder Atkar-Khattra
RMRenelle Myers
Renelle Myers
SLStephen Lam
Stephen Lam
Long-term exposure to ambient fine particulate matter air pollution (PM2.5) is a major risk factor for lung cancer and other chronic diseases. However, assigning individualized long-term exposure estimates, both at the point of care and in epidemiologic research, remains a methodological challenge due to limited tools for integrating residential history with air pollution data. As a result, most studies estimate exposure based only on a participant's last recorded address. Here, we describe and demonstrate the use of the Air Pollution EXposure (APEX) tool, a web-based application that provides individual annual estimates for PM2.5 exposure from 1998 to 2024 based on a user-provided residential history. APEX can collect address histories through a user-friendly web interface to collect worldwide addresses with autocompletion and interactive map facilitating recall of partial addresses. Addresses are geocoded and linked to annual surface-level PM2.5 estimates. APEX also supports both single-entry and batch-processing entry modes for integration in clinical and research workflows. APEX outputs annual PM2.5 exposure values, geocoded address logs, and graphical summaries. APEX-derived exposure estimates have been used to support an epidemiologic analysis evaluating the association between PM2.5 and lung cancer risk. APEX enables scalable, reproducible, and clinically applicable PM2.5 exposure assessment, facilitating personalized evaluation for risk assessment and epidemiologic research for lung cancer, cardiovascular disease, and other conditions associated with air pollution.

19 July 2026 in The Journal of Pathology: Clinical Research
Verified
Journal Article
Open access
LFLucas C Fung
Lucas C Fung
BJBrenden Joseph
Brenden Joseph
KOKenneth Ofori‐Amanfo
Kenneth Ofori‐Amanfo
TLTheodora Lo
Theodora Lo
PWPeiyao Wang
Peiyao Wang
ELEmilia L Lim
Emilia L Lim
Air pollution, such as particulate matter with a diameter of ≤2.5 μm (PM 2.5 ) is a major contributor to lung cancer in the never‐smoking population. Anthracotic pigments (black deposits in the lungs) are physical evidence of environmental exposures. While links between anthracosis and lung disease have been established, anthracosis has not been routinely used as a measure of environmental exposure in research, because there is neither a standard quantitative measure of anthracosis nor an efficient method for quantifying it. We developed ‘Slide‐based methods for High‐throughput Anthracosis Detection and Estimation’ (SHADE). SHADE is an automated workflow that quantifies anthracotic pigments on scanned images of whole H&E slides. SHADE was optimized to identify anthracosis while avoiding detection of artefacts in images. SHADE scores and manual pathologist rankings of 10‐image patches demonstrated high concordance ( R = 0.864). Application of SHADE to background lung sections from 140 never‐smoking lung cancer patients demonstrated significant associations between high anthracosis and older age, male sex, 30‐year residential PM 2.5 estimates, and birthplace in Asia ( p < 0.05). Low anthracosis was associated with less aggressive adenocarcinomas ( p = 0.052). No significant relationship was identified between anthracosis and 3‐year residential PM 2.5 estimates, lobe sampled, ethnicity, EGFR mutation status or pathologic tumor stage. Anthracosis levels in the never‐smoking cohort were similar to that of background lung sections from 59 ever‐smoking patients. Exploratory analysis of background lung sections of 15 individuals who had bronchoalveolar lavage specimen gene expression data available, SHADE scores were associated with the expression of several immunoregulatory genes ( CEACAM6 , CXCL6 , IL5RA , LCN2 , SPA17 ), the activation of inflammatory response and cytokine gene sets, and suppression of the antigen processing and presentation gene set (false discovery rate < 0.1). SHADE provides an automated workflow for anthracosis quantification and has demonstrated utility in uncovering insight into anthracosis‐associated molecular changes in lung cancer.